Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: Real-life effectiveness and safety from the PROSPECT study
Journal of the European Academy of Dermatology and Venereology | Nov 01, 2019
Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): A post hoc analysis of the BRIDGE study
Journal of the European Academy of Dermatology and Venereology | Nov 01, 2019
Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: A prospective cohort study
Journal of the European Academy of Dermatology and Venereology | Oct 31, 2019
Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: Real-life effectiveness and safety from the PROSPECT study
Journal of the European Academy of Dermatology and Venereology | Oct 25, 2019